Company profile: OralDNA Labs
1.1 - Company Overview
Company description
- Provider of salivary diagnostics services to treat, heal, and inspire oral health, offering a wide range of tests including DNA polymerase chain reaction (PCR) and next-generation sequencing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to OralDNA Labs
Biocytogen
HQ: China
Website
- Description: Provider of integrated solutions for antibody drug development, offering RenMab Mouse for fully human antibody discovery, RenLite for bispecific and multispecific antibody discovery, RenNano for heavy-chain-only antibodies, CRISPR/Cas9 gene editing to create humanized animal models, BioMice genetically modified models, and a bispecific ADC discovery platform targeting multiple tumor proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocytogen company profile →
Congenica
HQ: United Kingdom
Website
- Description: Provider of a clinical genomic diagnostic decision support platform. Sapientia integrates human DNA sequences with deep clinical phenotyping to enable actionable interpretation. Offerings include automated analysis for inherited diseases, somatic oncology, rare disease diagnosis, pathogen surveillance and pharma insights, upcoming pharmacogenomics, plus professional services for implementation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Congenica company profile →
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
OncoMark
HQ: Ireland
Website
- Description: Provider of companion diagnostic tests for cancer patient stratification. An Irish UCD spin-out, the company develops diagnostics to support cancer drug development, enabling pharmaceutical companies to select patients for whom a drug may be particularly effective, and tests that can also be used during clinical trials to help reduce the numbers of patients required.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoMark company profile →
Verinata Health
HQ: United States
Website
- Description: Provider of non-invasive tests for early identification of fetal chromosomal abnormalities, using proprietary technologies to enhance maternal and fetal health and reduce anxiety associated with the current multi-step process and false positives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verinata Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for OralDNA Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OralDNA Labs
2.2 - Growth funds investing in similar companies to OralDNA Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for OralDNA Labs
4.2 - Public trading comparable groups for OralDNA Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →